We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
Submission dates and how the submissions using the EC decision reliance procedure work.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Documents, certificate, letters, and notes available from the British embassy and consulates in the USA.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Find out how to import your personal belongings, pets and private motor vehicles when moving or returning to the UK.
British travellers to the US must register with the Electronic System for Travel Authorisation (ESTA) before their journey
Explanation of terms used in Ofsted's official and national statistical releases.
Submissions related to human medicines need to be submitted directly to the MHRA.
How to use an interrupted time series to evaluate your digital health product.
What to do if you think you are a victim of identity theft or fraud, and what signs to look out for.
The New Active Substance Work Sharing Initiative (NASWSI) has successfully approved several medicines through this international collaboration and continues to foster cooperation and strong relationships between its Access partners. The Biosimilar Work Sharing Initiative (BSWSI) builds on this success.
Learn how to check if your website or mobile app is accessible.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
How to get scientific advice about your licence application from MHRA, including: submitting a request, your meeting with MHRA, fees.
A list of upcoming webinars on the UK’s approach to product marking and placing products on the market in Great Britain and Northern Ireland.
Emergency alerts are broadcast from mobile phone masts. Find out if your phone or tablet can receive alerts.
How investigators and sponsors should manage clinical trials during COVID-19
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.